Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

NCT03800381 · clinicaltrials.gov ↗

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Human Immunodeficiency Virus
Coinfection

Interventions

OTHER: Observational PK study

Sponsor

University of Florida

Collaborators

[object Object]